No Data
No Data
Correction to Bristol-Myers Squibb 2024 Guidance Headline on July 26
OS Therapies Appoints Two Bio-Pharmaceutical Industry Veterans to the Board of Directors
Slow Day to Start Busy Week | Wall Street Today
Market Climbs as Investors Prepare for Biggest Earnings Week of the Year | Live Stock
Bristol Myers Shares New Data on COBENFY for Schizophrenia at Psych Congress, Highlighting Long-Term Safety and Patient Satisfaction
Bristol Myers Squibb to Present New Clinical and Health Economics and Outcomes Research Data at Psych Congress 2024
1038116155 : Nyi Nyi Htwe Y324412